These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7941276)

  • 41. Dose-response relationships for edrophonium antagonism of mivacurium-induced neuromuscular block during N2O-enflurane-alfentanil anaesthesia.
    Marcotte J; Drolet P; Perreault L; Girard M
    Can J Anaesth; 1995 Oct; 42(10):879-83. PubMed ID: 8706197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Edrophonium increases mivacurium concentrations during constant mivacurium infusion, and large doses minimally antagonize paralysis.
    Hart PS; Wright PM; Brown R; Lau M; Sharma ML; Miller RD; Gruenke L; Fisher DM
    Anesthesiology; 1995 Apr; 82(4):912-8. PubMed ID: 7717563
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The influence of atropine dose on recovery from vecuronium-induced neuromuscular blockade.
    Baurain MJ; Dernovoi BS; d'Hollander AA; Barvais L
    Anesthesiology; 1992 Jul; 77(1):17-20. PubMed ID: 1351705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Edrophonium antagonism of pancuronium-induced neuromuscular blockade in man: a reappraisal.
    Kopman AF
    Anesthesiology; 1979 Aug; 51(2):139-42. PubMed ID: 453615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine.
    Fleming NW; Macres S; Antognini JF; Vengco J
    Br J Anaesth; 1996 Oct; 77(4):492-5. PubMed ID: 8942334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Some actions of Org NC 45 and of edrophonium in the anaesthetized cat and in man.
    Baird WL; Bowman WC; Kerr WJ
    Br J Anaesth; 1982 Apr; 54(4):375-85. PubMed ID: 6121569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antagonism of mivacurium-induced neuromuscular blockade in humans. Edrophonium dose requirements at threshold train-of-four count of 4.
    Kopman AF; Mallhi MU; Justo MD; Rodricks P; Neuman GG
    Anesthesiology; 1994 Dec; 81(6):1394-400. PubMed ID: 7992908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The maximum depth of an atracurium neuromuscular block antagonized by edrophonium to effect adequate recovery.
    Beemer GH; Goonetilleke PH; Bjorksten AR
    Anesthesiology; 1995 Apr; 82(4):852-8. PubMed ID: 7717555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neostigmine, pyridostigmine, and edrophonium as antagonists of pancuronium.
    Ferguson A; Egerszegi P; Bevan DR
    Anesthesiology; 1980 Nov; 53(5):390-4. PubMed ID: 7425377
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction of verapamil with gallamine and pancuronium and reversal of combined neuromuscular blockade with neostigmine and edrophonium.
    Wali FA
    Eur J Anaesthesiol; 1986 Sep; 3(5):385-93. PubMed ID: 3780695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Split-dose atropine versus glycopyrrolate with neostigmine for reversal of gallamine-induced neuromuscular blockade.
    Wetterslev J; Jarnvig I; Jørgensen LN; Olsen NV
    Acta Anaesthesiol Scand; 1991 Jul; 35(5):398-401. PubMed ID: 1832261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Priming reversal of profound atracurium blockade by edrophonium and neostigmine.
    Liu CH; Lin IS; Liu CG; Peng TH; Yeh YJ; Chuu LJ; Lin SY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 May; 11(5):257-64. PubMed ID: 7602663
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade.
    Donati F; Smith CE; Bevan DR
    Anesth Analg; 1989 Jan; 68(1):13-9. PubMed ID: 2910133
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Edrophonium priming for antagonism of atracurium neuromuscular blockade.
    Szalados JE; Donati F; Bevan DR
    Can J Anaesth; 1990 Mar; 37(2):197-201. PubMed ID: 2311149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Twitch depression and train-of-four ratio after antagonism of pancuronium with edrophonium, neostigmine, or pyridostigmine.
    Donati F; Ferguson A; Bevan DR
    Anesth Analg; 1983 Mar; 62(3):314-6. PubMed ID: 6299135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potentiation of pancuronium and vecuronium neuromuscular blockade by intravenous salbutamol.
    Salib Y; Donati F
    Can J Anaesth; 1993 Jan; 40(1):50-3. PubMed ID: 8093860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium.
    Suzuki T; Lien CA; Belmont MR; Tjan J; Savarese JJ
    Can J Anaesth; 2003 Nov; 50(9):879-85. PubMed ID: 14617582
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effects of halothane and sevoflurane on reversal of neuromuscular blockade induced by vecuronium in man].
    Izawa H; Takeda J; Fukushima K
    Masui; 1997 Feb; 46(2):177-83. PubMed ID: 9071099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Neuromuscular blockade following high-dose vecuronium administration].
    Otagiri T; Nishizawa M; Narita M; Kiyono S
    Masui; 1990 Feb; 39(2):174-83. PubMed ID: 1969971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.